EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer

Gengdu Qin, Penglin Pan, Yang Qin, Ruozheng Wei, Yuhan Zhao, Qixun Fu, Haixin Yu, Jiaying Liu, Heshui Wu, Zhiqiang Liu, Yingke Zhou

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Gengdu Qin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Sino-G…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Oxidative Phosphorylation, Proto-Oncogene Proteins c-myc, Ubiquitin-Protein Ligases. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wuhan Union Hospital, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNF43 is frequently inactivated by mutations in pancreatic ductal adenocarcinoma (PDAC), but the molecular mechanisms and therapeutic vulnerabilities associated with RNF43 loss remain poorly defined. Here, we demonstrate that RNF43 functions as an E3 ubiquitin ligase targeting YBX1 for degradation, thereby suppressing mitochondrial oxidative phosphorylation (OXPHOS). In RNF43-deficient PDAC models, stabilized YBX1 activates MYC through dual mechanisms-enhancing MYC mRNA stability via IGF2BP1 and physically interacting with c-Myc protein-leading to transcriptional upregulation of IDH2 and IDH3A and subsequent OXPHOS activation. Importantly, RNF43 loss conferred sensitivity to OXPHOS inhibition both in vitro and in vivo. Treatment with the OXPHOS inhibitor IACS-010759 suppressed the proliferation, migration, invasion, and metastasis of RNF43-mutant tumors. Our findings identify a RNF43-YBX1-MYC signaling axis associated with metabolic reprogramming in pancreatic cancer and suggest that OXPHOS inhibition may represent a potential therapeutic vulnerability in tumors with RNF43-inactivating mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsOxidative PhosphorylationProto-Oncogene Proteins c-mycUbiquitin-Protein LigasesCarcinoma, Pancreatic DuctalY-Box-Binding Protein 1DNA-Binding ProteinsHumansAnimalsCell Line, TumorCell MovementCell ProliferationSignal TransductionMetabolic ReprogrammingGene Expression Regulation, NeoplasticMitochondriaMutationNeoplasm Invasiveness

Substanzen

Proto-Oncogene Proteins c-mycUbiquitin-Protein LigasesYBX1 protein, humanY-Box-Binding Protein 1MYC protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Sino-German Laboratory of Personalized Medicine for Pancreatic Cancer, Union…
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Förderung

  • Wuhan Union Hospital
  • National Natural Science Foundation of China

Zitieren

APA

Qin, G., Pan, P., Qin, Y., Wei, R., Zhao, Y., Fu, Q., Yu, H., Liu, J., Wu, H., Liu, Z., & Zhou, Y. (2026). RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218560

Vancouver

Qin G, Pan P, Qin Y, Wei R, Zhao Y, Fu Q, et al. RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218560

BibTeX
@article{Qin2026,
  author = {Qin, Gengdu and Pan, Penglin and Qin, Yang and Wei, Ruozheng and Zhao, Yuhan and Fu, Qixun and Yu, Haixin and Liu, Jiaying and Wu, Heshui and Liu, Zhiqiang and Zhou, Yingke},
  title = {RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218560}
}
Kostenlos starten →